{"id":"hyperpolarized-xenon-129","safety":{"commonSideEffects":[{"rate":null,"effect":"Minimal adverse events reported; generally well-tolerated"}]},"_chembl":{"chemblId":"CHEMBL4594411","moleculeType":"Small molecule","molecularWeight":"128.90"},"_dailymed":{"setId":"70e33fe3-c722-439b-b3db-c2a22f229c8a","title":"XENOVIEW (XENON XE 129 HYPERPOLARIZED) GAS [POLAREAN, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Xenon-129 is a noble gas that is hyperpolarized (aligned nuclear spins) to dramatically increase its magnetic resonance signal. When inhaled, it distributes throughout ventilated lung regions and can diffuse across the alveolar-capillary membrane into red blood cells and tissue, allowing MRI to visualize regional ventilation, perfusion, and gas exchange in unprecedented detail without ionizing radiation.","oneSentence":"Hyperpolarized xenon-129 is an inhaled contrast agent that enhances lung MRI by providing increased signal from ventilated airspaces, enabling detailed visualization of pulmonary function and gas exchange.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:47:47.506Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pulmonary MRI imaging in patients with chronic obstructive pulmonary disease (COPD)"},{"name":"Assessment of regional lung ventilation and perfusion"},{"name":"Evaluation of asthma and other obstructive airway diseases"}]},"trialDetails":[{"nctId":"NCT07046910","phase":"PHASE2","title":"Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2019-04-01","conditions":"Lung Transplant Rejection","enrollment":60},{"nctId":"NCT06856525","phase":"PHASE2, PHASE3","title":"Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology","status":"RECRUITING","sponsor":"Y. Michael Shim, MD","startDate":"2024-12-19","conditions":"Electronic Cigarette Related Lung Damage","enrollment":80},{"nctId":"NCT02740868","phase":"PHASE2","title":"Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease","status":"RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2015-08","conditions":"Cystic Fibrosis, Asthma","enrollment":30},{"nctId":"NCT06104228","phase":"PHASE2","title":"129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2024-08-12","conditions":"Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)","enrollment":20},{"nctId":"NCT05241275","phase":"PHASE2","title":"Xenon MRI and Progressive ILD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2022-07-19","conditions":"Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis","enrollment":60},{"nctId":"NCT06351345","phase":"PHASE2","title":"129 Xenon Imaging in Patients Treated With Sotatercept","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2025-10-27","conditions":"Pulmonary Hypertension, Pulmonary Arterial Hypertension","enrollment":14},{"nctId":"NCT06909201","phase":"PHASE1","title":"Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity","status":"SUSPENDED","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-10-16","conditions":"Lung Cancer","enrollment":70},{"nctId":"NCT02272049","phase":"PHASE1, PHASE2","title":"Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2014-12","conditions":"Respiratory Disorders","enrollment":300},{"nctId":"NCT06012500","phase":"PHASE1, PHASE2","title":"Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-04-14","conditions":"ILD","enrollment":78},{"nctId":"NCT05041140","phase":"","title":"Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-08-14","conditions":"Pulmonary, Pneumonia, Hematopoietic System--Cancer","enrollment":25},{"nctId":"NCT04035629","phase":"PHASE1","title":"129Xe MRI in Pediatric Population With BPD","status":"WITHDRAWN","sponsor":"Xemed LLC","startDate":"2026-08-01","conditions":"Bronchopulmonary Dysplasia","enrollment":""},{"nctId":"NCT06038630","phase":"PHASE2","title":"129Xe MRI Cardiopulmonary","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2024-01-12","conditions":"Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism","enrollment":125},{"nctId":"NCT04467957","phase":"PHASE4","title":"Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-11-15","conditions":"Cystic Fibrosis","enrollment":26},{"nctId":"NCT05302817","phase":"PHASE1","title":"Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2023-03-17","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":9},{"nctId":"NCT05816616","phase":"","title":"Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation","status":"WITHDRAWN","sponsor":"Xemed LLC","startDate":"2025-09-01","conditions":"COPD","enrollment":""},{"nctId":"NCT06339593","phase":"EARLY_PHASE1","title":"Regional Monitoring of CF Lung Disease","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2024-01-05","conditions":"Cystic Fibrosis","enrollment":60},{"nctId":"NCT04995562","phase":"PHASE4","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Infants","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-05-06","conditions":"Lungs; Developmental Disorder","enrollment":12},{"nctId":"NCT04071769","phase":"PHASE2","title":"Genentech Xenon MRI Idiopathic Pulmonary Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2020-08-03","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":34},{"nctId":"NCT05914506","phase":"","title":"Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2023-10-05","conditions":"Progressive Fibrosing Interstitial Lung Disease","enrollment":30},{"nctId":"NCT02220426","phase":"PHASE1","title":"Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-09-01","conditions":"Obesity","enrollment":17},{"nctId":"NCT07139899","phase":"","title":"Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2025-11-17","conditions":"Severe Asthma","enrollment":5},{"nctId":"NCT03603899","phase":"PHASE1, PHASE2","title":"Hp129 Xenon Imaging and BOS in Lung Transplantation","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2020-09-09","conditions":"Bronchiolitis Obliterans","enrollment":3},{"nctId":"NCT04941573","phase":"","title":"Assessment of Chronic Lung Allograft Dysfunction Using Single-breath & Multi-breath Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2021-01-19","conditions":"Lung Transplant Rejection","enrollment":45},{"nctId":"NCT05433961","phase":"PHASE1","title":"Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI","status":"TERMINATED","sponsor":"Xemed LLC","startDate":"2023-10-20","conditions":"COPD","enrollment":27},{"nctId":"NCT02316379","phase":"PHASE1, PHASE2","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2015-02","conditions":"Respiratory Disorders","enrollment":100},{"nctId":"NCT05550662","phase":"PHASE2","title":"HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2024-02-07","conditions":"Lung Transplant Rejection","enrollment":6},{"nctId":"NCT04726618","phase":"","title":"Development of Hardware and Software for Pulmonary Magnetic Resonance Imaging Using Inhaled Tracer Gases","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2022-03-01","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT02195206","phase":"","title":"Hyperpolarized Xenon-129 Lung and/or Brain Magnetic Resonance Imaging: Healthy Adult Volunteer Pilot Study","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2014-07","conditions":"Healthy","enrollment":40},{"nctId":"NCT03909477","phase":"","title":"Longitudinal Study of Xenon-129 MRI Imaging Effects of Cannabis Smoking","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2022-06-01","conditions":"Cannabis Use, Cannabis Smoking, Marijuana Smoking","enrollment":200},{"nctId":"NCT04616313","phase":"","title":"Novel Pulmonary Imaging of Lung Structure and Function in E-cigarette Smokers","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2023-01-17","conditions":"E Cigarette Use","enrollment":150},{"nctId":"NCT04584671","phase":"","title":"Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Western University, Canada","startDate":"2021-01-01","conditions":"Covid19","enrollment":100},{"nctId":"NCT03733535","phase":"NA","title":"Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Grace Parraga","startDate":"2022-03-01","conditions":"Asthma; Eosinophilic","enrollment":29},{"nctId":"NCT06853145","phase":"EARLY_PHASE1","title":"Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2025-05-01","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":6},{"nctId":"NCT06985225","phase":"","title":"Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2025-06","conditions":"Severe Asthma","enrollment":5},{"nctId":"NCT04624490","phase":"PHASE1","title":"Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease","status":"RECRUITING","sponsor":"Mario Castro, MD, MPH","startDate":"2020-11-02","conditions":"Asthma, COPD, Interstitial Lung Disease","enrollment":260},{"nctId":"NCT04659707","phase":"PHASE1","title":"Hyperpolarized 129Xe MRI of Survivors of COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2021-02-22","conditions":"Covid19","enrollment":20},{"nctId":"NCT05204355","phase":"","title":"MRI for Screening and Monitoring Scleroderma ILD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-05-01","conditions":"Scleroderma","enrollment":25},{"nctId":"NCT05766384","phase":"","title":"Hyperpolarized 129Xe MRI Lung Health Cohort","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-11-30","conditions":"Healthy","enrollment":260},{"nctId":"NCT05339386","phase":"","title":"Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-08-29","conditions":"Pulmonary Arterial Hypertension","enrollment":10},{"nctId":"NCT06819969","phase":"","title":"The Canadian Lung Outcomes in Users of Vaping Devices Study","status":"NOT_YET_RECRUITING","sponsor":"University of British Columbia","startDate":"2025-02","conditions":"Small Airways Diseases, Vaping, Vaping Related Disorder","enrollment":500},{"nctId":"NCT03002389","phase":"PHASE2","title":"Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Virginia","startDate":"2017-11-05","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":95},{"nctId":"NCT02638519","phase":"EARLY_PHASE1","title":"HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease","status":"TERMINATED","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2016-06-27","conditions":"Alzheimer Disease","enrollment":51},{"nctId":"NCT02748798","phase":"EARLY_PHASE1","title":"Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders","status":"TERMINATED","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2020-11-10","conditions":"Lung Transplant, Lung Resection, Lung Cancer","enrollment":10},{"nctId":"NCT02723500","phase":"NA","title":"129 Xenon MRI in Chronic Lung Disease","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2011-08","conditions":"Lung Disease","enrollment":100},{"nctId":"NCT03455686","phase":"NA","title":"Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease","status":"RECRUITING","sponsor":"McMaster University","startDate":"2018-04-19","conditions":"Asthma, Chronic Obstructive Pulmonary Disease, Bronchiectasis","enrollment":60},{"nctId":"NCT06271408","phase":"PHASE1","title":"Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging","status":"UNKNOWN","sponsor":"Polarean, Inc.","startDate":"2024-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":6},{"nctId":"NCT06122922","phase":"PHASE2","title":"Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)","status":"WITHDRAWN","sponsor":"Bastiaan Driehuys","startDate":"2024-03-15","conditions":"Pulmonary Artery Hypertension","enrollment":""},{"nctId":"NCT03367312","phase":"PHASE2","title":"Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2018-03-29","conditions":"Pulmonary Vascular Disease","enrollment":11},{"nctId":"NCT02723513","phase":"NA","title":"Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD","status":"COMPLETED","sponsor":"Western University, Canada","startDate":"2016-04-01","conditions":"Bronchopulmonary Dysplasia, Preterm Birth","enrollment":3},{"nctId":"NCT03632369","phase":"","title":"Hyperpolarized Noble Gas MRI Detection of Radiation-Induced Lung Injury","status":"WITHDRAWN","sponsor":"Thunder Bay Regional Health Research Institute","startDate":"2016-12","conditions":"Radiation Induced Lung Injury, Non Small Cell Lung Cancer","enrollment":""},{"nctId":"NCT02151604","phase":"PHASE2","title":"Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy","status":"COMPLETED","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2014-04-23","conditions":"Non-small Cell Lung Cancer","enrollment":22},{"nctId":"NCT02478255","phase":"PHASE2","title":"Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2016-03-21","conditions":"Radiation Injury","enrollment":25},{"nctId":"NCT03884842","phase":"PHASE3","title":"Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma.","status":"COMPLETED","sponsor":"McMaster University","startDate":"2019-07-01","conditions":"Asthma","enrollment":24},{"nctId":"NCT04677426","phase":"PHASE2","title":"129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2022-05-01","conditions":"Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis","enrollment":""},{"nctId":"NCT03078192","phase":"PHASE2","title":"Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2017-05-03","conditions":"Pulmonary Vascular Disease","enrollment":62},{"nctId":"NCT02478268","phase":"PHASE1","title":"Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"Bastiaan Driehuys","startDate":"2015-05","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":64},{"nctId":"NCT03482960","phase":"EARLY_PHASE1","title":"Comparison of 129Xe MRI With 19F MRI in CF Lung Disease","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-05-29","conditions":"Cystic Fibrosis","enrollment":11},{"nctId":"NCT04662658","phase":"PHASE1, PHASE2","title":"Hyperpolarized Xenon-129 MR Imaging of the Lung","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2020-11-05","conditions":"E-Cig Use","enrollment":24},{"nctId":"NCT02826343","phase":"EARLY_PHASE1","title":"New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2016-05-01","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":30},{"nctId":"NCT03331302","phase":"PHASE1, PHASE2","title":"Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2018-09-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":30},{"nctId":"NCT04029636","phase":"","title":"Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPC","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2019-08","conditions":"Bronchiolitis Obliterans","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":88,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["129HxeMRI","129Xe"],"phase":"marketed","status":"active","brandName":"Hyperpolarized xenon 129","genericName":"Hyperpolarized xenon 129","companyName":"Y. Michael Shim, MD","companyId":"y-michael-shim-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hyperpolarized xenon-129 is an inhaled contrast agent that enhances lung MRI by providing increased signal from ventilated airspaces, enabling detailed visualization of pulmonary function and gas exchange. Used for Pulmonary MRI imaging in patients with chronic obstructive pulmonary disease (COPD), Assessment of regional lung ventilation and perfusion, Evaluation of asthma and other obstructive airway diseases.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}